Skip to main content

Labor, Premature

0
Pipeline Programs
3
Companies
3
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

3 companies ranked by most advanced pipeline stage

Juniper Biosciences
Juniper BiosciencesNJ - Bridgewater
1 program
Vaginal progesterone gelN/A1 trial
Active Trials
NCT01206998Withdrawn0Est. Aug 2010
Human BioSciences
Human BioSciencesWV - Martinsburg
1 program
cervical cerclageN/A1 trial
Active Trials
NCT00059683Completed300Est. Oct 2009
Ferring Pharmaceuticals
Ferring PharmaceuticalsArgentina - Buenos Aires
1 program
FE200440PHASE_21 trial
Active Trials
NCT00209326Completed163Est. Aug 2006

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Ferring PharmaceuticalsFE200440
Juniper BiosciencesVaginal progesterone gel
Human BioSciencescervical cerclage

Clinical Trials (3)

Total enrollment: 463 patients across 3 trials

NCT00209326Ferring PharmaceuticalsFE200440

A Proof of Concept Study Assessing the Effect of Four Different Single Bolus Intravenous Doses of FE200440 and Placebo on Stopping Preterm Labor

Start: Nov 2003Est. completion: Aug 2006163 patients
Phase 2Completed
NCT01206998Juniper BiosciencesVaginal progesterone gel

Vaginal Progesterone as a Treatment for Women Active Preterm Labor

Start: Jul 2010Est. completion: Aug 20100
N/AWithdrawn
NCT00059683Human BioSciencescervical cerclage

Ultrasound-indicated Cerclage to Prevent Premature Birth in High-risk Women

Start: Jan 2003Est. completion: Oct 2009300 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

3 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.